Navigation Links
ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
Date:10/3/2007

A registered ReBuilder System(R), used for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) that depend on prescription drugs with powerful side effects, the ReBuilder System(R) is a portable, battery- powered medical product that provides a unique, non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.

ReBuilder Medical Technologies, Inc. also manufactures the Phillips Molluscum Treatment System(TM) for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum pathogen without side effects. The company is currently performing research and development on a number of other products as well.

ReBuilder Medical Technologies, Inc. is located in Charles Town, WV. CEO, Dr. David Phillips, Ph.D. is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System, which is used for the early detection of breast cancer, and the AcuPen, a hand-held device that provides the benefits of acupuncture without the use of needles.

More information on ReBuilder Medical Technologies, Inc. and its products can be found at: http://www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market
'/>"/>

SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Check if your “Favourite medical web-site” is indulging in Quackey
2. Teens turning to Internet for medical queries
3. Robots craft medical history
4. NBE to conduct test for medical students from abroad
5. Air pollution combined with greater medical needs
6. Indian Nationals with Foreign Medical Degrees can now practice in India
7. Children! Protecting them from medical mistakes
8. More information sought by patients on medical errors
9. SARS necessitates medical masks
10. Meditation Works Medically
11. Sleep Disorders Could Indicate Other Medical Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)...ence Call Scheduled Tuesday, August 5, 2008 at 11:...e-FirstCall/ -- Almost Family, Inc.,(Nasdaq: AFAM...sing,services, announced today that it will report..., 2008 on Tuesday, August 5, 2008, before the,mark... will begin at 11:00 a.m. ET on,August 5, 2008 and...
(Date:7/23/2008)...ON, N.J., July 23 /PRNewswire-USNewswire/ -- The N...lity and Patient Safety has,received a planning gr...dation (RWJF) to develop a proposal for improving ...nt will help determine over the next six months wh...ning Forces for Quality initiative,which is focus...
(Date:7/23/2008)..., China, July 23 /Xinhua-PRNewswire-FirstCall/ -- ...letin Board: GTEC) ("Genesis" or,the "Company"), a...public,of China, held a Board of Directors meeting...appointed to serve on the Board of Directors of th...on Committee were formed., Mr. Michael Marks was ...
(Date:7/23/2008)...ERSBURG, Fla., July 23 /PRNewswire/ -- Laura Kolkm...gnized health information exchange,consulting firm...hcare,Information and Management Systems Society (...ing Committee., The HIE Steering Committee, which...ng providers, payers, vendors, consultants and lif...
Breaking Medicine News(10 mins):Health News:Almost Family, Inc. to Report Second Quarter 2008 Financial Results 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 2Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 3Health News:Genesis Pharmaceuticals Announces New Board Member and Forms Committees 4Health News:Mosaica Partners' Kolkman to Chair HIMSS Healthcare Information Exchange Steering Committee 2
...cer trials has confirmed that a combination therap...herapy improves survival in women with operable HE...e University of Athens conducted the meta-analysis...000 women whose breast cancer was amenable to surg...
...snack while driving then don't, for a new study ha... of accidents . Researchers at Brunel University ...r drinking at the wheel has any effect on a person...nd they are nearly twice as likely to be taken by ...
...n could also serve to repress an alcoholic's desir...rs at the University of California-San Francisco .... as a smoking cessation aid in the United States a... reduce nicotine consumption by affecting the brai...
...g 150,000 HIV sufferers with free anti-retroviral ... AIDS commission (NAC) said on Monday . "We are c...150,000 by the end of December when we launch a ma... drugs" from September, NAC chief Biziwick Mwale t...
Other Medicine News:Health News:Snacking While Driving Doubles Accident Rates 2
(Date:7/22/2008)...and Efficacy of Treating Patients with ..., and YONGIN-SI, South Korea, July 22 /PRNewswire/...Ontario), and its South,Korean partner Green Cross... Phase I clinical trial of its first-in-class lead...well-tolerated and resulted in clear,anti-cancer e...
(Date:7/22/2008)...the Importance to Patients of Passing a ...MOND, Va., July 22 /- Insme...biologics and biopharmaceuticals, today,announced ...esent at a,Congressional briefing on Friday, July ...ablishing an approval pathway for follow-on,biolog...
(Date:7/22/2008)...lumbia University Medical Center Based on ...y, The Test Differentiates Squamous From Non-Squ...ying Squamous-Cell Carcinoma of the Lung With ... Percent,This is the First CLIA Approved Test Whic...markers for Accurate Diagnosis of Lung Cancer, RE...
(Date:7/22/2008)...s Genetic Risk Based on Clinical Data, Preventi...erials, WALTHAM, Mass., July 22 /PRNewswire-First... today announced the launch of an enhanced test re...y,s Heart Health Genetic Test.,The test is current...Health,Genetic Test by Quixtar/Amway. The new repo...
Breaking Medicine Technology:Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 2Interleukin Genetics Launches Enhanced Heart Health Genetic Test Report Format 3bioMETRX Inc Calls Series B Warrants 231 1bioMETRX Inc Calls Series B Warrants 231 2M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution 228 1M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution 228 2Bacteria from sponges make new pharmaceuticals 226 1Bacteria from sponges make new pharmaceuticals 226 2Hidden interactions between predators and prey 3A evolution causes cryptic dynamics in ecology 223 1Hidden interactions between predators and prey 3A evolution causes cryptic dynamics in ecology 223 2
...conomic advantages of nifedipine,GITS therapy , ,... recently,published articles in the Journal of Cli...he use of the long-acting calcium channel,blocker ...l,benefits beyond its blood pressure lowing effect...of Clinical Epidemiology,2007; first published onl...
...Mar 27, 2007 - Interleukin,Genetics, Inc. (AMEX:IL...ia San Diego today reported at the American Colleg...etween coronary artery,disease (CAD) and both oxid...to be dependent on pro-inflammatory variants of th...itled "The Influence of Oxidized,Phospholipids and...
Other Medicine Technology:Calcium Channel Blocker Adalat GITS Offer Additional Benefits 2Calcium Channel Blocker Adalat GITS Offer Additional Benefits 3ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3
...ue processor features superior user comfort with s...closed, stand-alone system for processing of up to...ocessor combines proven technology with an innovat... use,yet powerful software. Many routine user oper...
...mily are semi-enclosed tissue processors. The Leic...nology with modern and functionally enhanced desig...or tissues at all stages of the processing run, ro...mechanics in conjunction with a modern user interf...
...w tissue infiltration instrument, which combines w...erly way. The robust caroussel design is proven an... instrument includes either 10 reagent and 2 paraf...ers. Up to 10 different programs can be stored all...
...with automatic fine/trim- feed system, specimen re...ecision cross roller bearings. For sectioning para...in biological, botany, and materials science. Spec...Performance, ergonomy and design of this sliding m...
Medicine Products: